誘導治療での高投与量シタラビンは46歳より若い急性骨髄性白血病成人患者の転帰を改善する: EORTC-GIMEMA AML-12試験
Willemze Roelof,Suciu Stefan,Meloni Giovanna,Labar Boris,Marie Jean-Pierre, J M Halkes Constantijn,Muus Petra, Mistrik Martin,Amadori Sergio,Specchia Giorgina,Fabbiano Francesco,Nobile Francesco,Sborgia Marco,Camera Andrea, L D Selleslag Dominik,Lefrere Francois,Magro Domenico,Sica Simona,Cantore Nicola, Beksac Meral,Berneman Zwi,Thomas Xavier,Melillo Lorella, E Guimaraes Jose,Leoni Pietro,Luppi Mario,E Mitra Maria,Bron Dominique,Fillet Georges, W A Marijt Erik,Venditti Adriano,Hagemeijer Anne,Mancini Marco,Jansen Joop,Cilloni Daniela, Meert Liv,Fazi Paola,Vignetti Marco, M Trisolini Silvia Journal of Clinical Oncology(2014)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)